Although at present, no direct correlation between GATA1 expression and CALR mutations is found, Brown et al12 observed a significant upregulation of CALR mRNA in MPN cases with high GATA‐1 and this could be relevant to the double immunohistochemistry staining in our study. The gene discussed is CALR; the disease is myeloproliferative disorder.